Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

PERT Consortium 2022

P. Monteleone

Metabolic Interventions in PAH

Cleveland Clinic Respiratory Institute

A. R Hemnes

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ACC 2023: Clinical Manifestations of Right Ventricular Failure

ACC 2023 Conference Coverage

J. Huston

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Pericardiocentesis in Pulmonary Hypertension

Chao-Wei Hwang

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Scripps Health

R. C. Mohan

Perioperative Risk Assessment & Management: When Do I Need Cardiac T…

Houston Methodist DeBakey Heart and Vascular Center

N. Faza

CHEST 2023 Insights: Pulmonary Hypertension Treatment - How to Start…

CHEST 2023 Insights

J. Elwing

What Is New in 2024 for Pulmonary Embolism

Temple Lung Center

P. Rali

Pulmonary Hypertension With Left Heart Disease

Scripps Health

T. Heywood

ATS 2022: Addressing Disparities in the Care of Pulmonary Hypertensi…

Vinicio De Jesus Perez

Sotatercept FDA Approval: A New Dawn in PAH Treatment

Temple Lung Center

A. Raza

Link Between Parenchymal Lung Disease and PH

UCLA Health

R. Saggar

Comprehensive Management of Acute Pulmonary Embolism

Medical College of Georgia - Augusta University

V. Arora

RV Failure and Pulmonary Hypertension

Inova Cherry Blossom Cardiovascular Symposium 2022

M. Psotka

ATS 2022: Midodrine as a Novel Tool to Optimize Pulmonary Hypertensi…

Zeenat Safdar

Hereditary Hemorrhagic Telangiectasia (HHT): An Overview

University of Colorado Department of Medicine

P. Hountras

Pulmonary Hypertension Update: Navigating the New Guidelines and Exp…

National Jewish Health

P. George